HP
HealthInvest Partners Portfolio holdings
AUM
$234M
1-Year Return
10.88%
This Quarter Return
-6.36%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$66.8M
AUM Growth
-$38.8M
(-37%)
Cap. Flow
-$33.2M
Cap. Flow
% of AUM
-49.66%
Top 10 Holdings %
Top 10 Hldgs %
84.33%
Holding
19
New
10
Increased
–
Reduced
7
Closed
2
Top Buys
| 1 |
Harmony Biosciences
HRMY
|
+$7.09M |
| 2 |
Rigel Pharmaceuticals
RIGL
|
+$6.41M |
| 3 |
LCI
Lannett Company, Inc.
LCI
|
+$5.33M |
| 4 |
Utah Medical Products
UTMD
|
+$3.9M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$3.34M |
Top Sells
| 1 |
Ironwood Pharmaceuticals
IRWD
|
+$10.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$10.5M |
| 3 |
Cigna
CI
|
+$9.72M |
| 4 |
McKesson
MCK
|
+$8.77M |
| 5 |
AbbVie
ABBV
|
+$7.55M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ironwood Pharmaceuticals
IRWD
$213M
| $8.95M | 13.4% |
685,000
-835,000
| -55% | -$10.9M |
|
2
Supernus Pharmaceuticals
SUPN
$2.55B
| $8.93M | 13.38% |
335,000
-195,000
| -37% | -$5.2M |
|
3
Accuray
ARAY
$177M
| $7.35M | 11% |
1,860,000
-440,000
| -19% | -$1.74M |
|
|
4
Harmony Biosciences
HRMY
$1.86B
| $7.09M | 10.62% |
+185,000
| New | +$7.09M |
|
|
5
Rigel Pharmaceuticals
RIGL
$681M
| $6.41M | 9.6% |
+176,500
| New | +$6.41M |
|
|
LCI
6
DELISTED
Lannett Company, Inc.
LCI
| $5.33M | 7.98% |
+443,750
| New | +$5.33M |
|
|
7
Utah Medical Products
UTMD
$200M
| $3.9M | 5.84% |
+42,000
| New | +$3.9M |
|
|
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
| $3.34M | 5.01% |
+220,000
| New | +$3.34M |
|
9
Aldeyra Therapeutics
ALDX
$324M
| $2.72M | 4.08% |
+310,000
| New | +$2.72M |
|
10
Evolus
EOLS
$465M
| $2.29M | 3.42% |
+300,000
| New | +$2.29M |
|
11
Cencora
COR
$58.7B
| $1.67M | 2.5% |
+14,000
| New | +$1.67M |
|
12
Bristol-Myers Squibb
BMY
$94B
| $1.66M | 2.48% |
28,000
-119,000
| -81% | -$7.04M |
|
|
13
AbbVie
ABBV
$386B
| $1.62M | 2.42% |
15,000
-70,000
| -82% | -$7.55M |
|
|
14
McKesson
MCK
$88.5B
| $1.6M | 2.39% |
8,000
-44,000
| -85% | -$8.77M |
|
15
Cardinal Health
CAH
$36.4B
| $1.58M | 2.37% |
32,000
-138,000
| -81% | -$6.83M |
|
16
UroGen Pharma
URGN
$869M
| $1.26M | 1.89% |
+75,000
| New | +$1.26M |
|
|
LJPC
17
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.08M | 1.61% |
+270,000
| New | +$1.08M |
|
|
18
Cigna
CI
$80.8B
| – | – |
-41,000
| Closed | -$9.72M |
|
|
19
Vertex Pharmaceuticals
VRTX
$101B
| – | – |
-52,000
| Closed | -$10.5M |
|